Qsemble Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-57,088	Closed	-$3.39M	–	454
2025 Q4	$3.39M	Buy	+57,088	New	+$3.11M	0.28%	123
2025 Q3	–	Sell	-21,827	Closed	-$1.2M	–	469
2025 Q2	$1.2M	Sell	21,827 -21,438	-50%	-$1.26M	0.12%	224
2025 Q1	$3.06M	Buy	43,265 +10,929	+34%	+$735K	0.32%	114
2024 Q4	$2.13M	Buy	+32,336	New	+$2.17M	0.28%	128
2024 Q2	–	Sell	-8,848	Closed	-$773K	–	435
2024 Q1	$773K	Sell	8,848 -960	-10%	-$85.9K	0.17%	205
2023 Q4	$946K	Sell	9,808 -8,592	-47%	-$760K	0.24%	160
2023 Q3	$1.63M	Buy	18,400 +7,100	+63%	+$632K	0.3%	117
2023 Q2	$979K	Buy	+11,300	New	+$1.06M	0.7%	56
2023 Q1	–	Sell	-8,100	Closed	-$838K	–	246
2022 Q4	$838K	Buy	+8,100	New	+$760K	0.58%	60